These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23698285)

  • 1. Monitoring the response to neoadjuvant hormone therapy for locally advanced breast cancer using three-dimensional time-resolved optical mammography.
    Enfield L; Cantanhede G; Douek M; Ramalingam V; Purushotham A; Hebden J; Gibson A
    J Biomed Opt; 2013 May; 18(5):56012. PubMed ID: 23698285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the response to primary medical therapy for breast cancer using three- dimensional time-resolved optical mammography.
    Enfield LC; Cantanhede G; Westbroek D; Douek M; Purushotham AD; Hebden JC; Gibson AP
    Technol Cancer Res Treat; 2011 Dec; 10(6):533-47. PubMed ID: 22066594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.
    Choe R; Corlu A; Lee K; Durduran T; Konecky SD; Grosicka-Koptyra M; Arridge SR; Czerniecki BJ; Fraker DL; DeMichele A; Chance B; Rosen MA; Yodh AG
    Med Phys; 2005 Apr; 32(4):1128-39. PubMed ID: 15895597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional time-resolved optical mammography of the uncompressed breast.
    Enfield LC; Gibson AP; Everdell NL; Delpy DT; Schweiger M; Arridge SR; Richardson C; Keshtgar M; Douek M; Hebden JC
    Appl Opt; 2007 Jun; 46(17):3628-38. PubMed ID: 17514325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index.
    Anderson PG; Kalli S; Sassaroli A; Krishnamurthy N; Makim SS; Graham RA; Fantini S
    Acad Radiol; 2017 Oct; 24(10):1240-1255. PubMed ID: 28532642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional hemodynamic imaging markers for the prediction of pathological outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
    Deng B; Muldoon A; Cormier J; Mercaldo ND; Niehoff E; Moffett N; Saksena MA; Isakoff SJ; Carp SA
    J Biomed Opt; 2024 Jun; 29(6):066001. PubMed ID: 38737790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
    Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
    J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.
    Zhu Q; Tannenbaum S; Hegde P; Kane M; Xu C; Kurtzman SH
    Neoplasia; 2008 Oct; 10(10):1028-40. PubMed ID: 18813360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.
    Tran WT; Gangeh MJ; Sannachi L; Chin L; Watkins E; Bruni SG; Rastegar RF; Curpen B; Trudeau M; Gandhi S; Yaffe M; Slodkowska E; Childs C; Sadeghi-Naini A; Czarnota GJ
    Br J Cancer; 2017 May; 116(10):1329-1339. PubMed ID: 28419079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.
    Dixon JM; Renshaw L; Bellamy C; Stuart M; Hoctin-Boes G; Miller WR
    Clin Cancer Res; 2000 Jun; 6(6):2229-35. PubMed ID: 10873072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study.
    Jakubowski DB; Cerussi AE; Bevilacqua F; Shah N; Hsiang D; Butler J; Tromberg BJ
    J Biomed Opt; 2004; 9(1):230-8. PubMed ID: 14715078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective.
    Dixon JM; Anderson TJ; Miller WR
    Eur J Cancer; 2002 Nov; 38(17):2214-21. PubMed ID: 12441257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers.
    Zhu Q; Kurtzma SH; Hegde P; Tannenbaum S; Kane M; Huang M; Chen NG; Jagjivan B; Zarfos K
    Neoplasia; 2005 Mar; 7(3):263-70. PubMed ID: 15799826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.
    Tromberg BJ; Cerussi A; Shah N; Compton M; Durkin A; Hsiang D; Butler J; Mehta R
    Breast Cancer Res; 2005; 7(6):279-85. PubMed ID: 16457705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
    Schaafsma BE; van de Giessen M; Charehbili A; Smit VT; Kroep JR; Lelieveldt BP; Liefers GJ; Chan A; Löwik CW; Dijkstra J; van de Velde CJ; Wasser MN; Vahrmeijer AL
    Clin Cancer Res; 2015 Feb; 21(3):577-84. PubMed ID: 25473002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadband optical mammography: chromophore concentration and hemoglobin saturation contrast in breast cancer.
    Anderson PG; Kainerstorfer JM; Sassaroli A; Krishnamurthy N; Homer MJ; Graham RA; Fantini S
    PLoS One; 2015; 10(3):e0117322. PubMed ID: 25781469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A; Font López KC; Amador DD
    Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer.
    Soliman H; Gunasekara A; Rycroft M; Zubovits J; Dent R; Spayne J; Yaffe MJ; Czarnota GJ
    Clin Cancer Res; 2010 May; 16(9):2605-14. PubMed ID: 20406836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo.
    Rinneberg H; Grosenick D; Moesta KT; Mucke J; Gebauer B; Stroszczynski C; Wabnitz H; Moeller M; Wassermann B; Schlag PM
    Technol Cancer Res Treat; 2005 Oct; 4(5):483-96. PubMed ID: 16173820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress.
    Xu C; Vavadi H; Merkulov A; Li H; Erfanzadeh M; Mostafa A; Gong Y; Salehi H; Tannenbaum S; Zhu Q
    Ultrason Imaging; 2016 Jan; 38(1):5-18. PubMed ID: 25887527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.